NCT00002923View on ClinicalTrials.gov

KRN5500 in Treating Patients With Metastatic Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

May 31, 1997

Primary Completion Date

January 31, 2000

Study Completion Date

October 31, 2000

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

KRN5500

Trial Locations (1)

48201

Barbara Ann Karmanos Cancer Institute, Detroit

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Barbara Ann Karmanos Cancer Institute

OTHER

NCT00002923 - KRN5500 in Treating Patients With Metastatic Solid Tumors | Biotech Hunter | Biotech Hunter